Michel Gallant

Person

Pierrefonds, CA

People

Patents Grantslast 30 patents

Information Patent Grant
Modulators of cystic fibrosis transmembrane conductance regulator
- Patent number 12,269,831
- Issue date Apr 8, 2025
- Vertex Pharmaceuticals Incorporated
- Jeremy J. Clemens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mannose derivatives for treating bacterial infections
- Patent number 11,634,447
- Issue date Apr 25, 2023
- Vertex Pharmaceuticals Incorporated
- Yeeman K. Ramtohul
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2,7-dibromospiro[fluorene-9,4′-piperidine] compounds
- Patent number 10,913,761
- Issue date Feb 9, 2021
- Vertex Pharmaceuticals Incorporated
- Yeeman K. Ramtohul
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Mannose derivatives for treating bacterial infections
- Patent number 10,669,298
- Issue date Jun 2, 2020
- Vertex Pharmaceuticals Incorporated
- Yeeman K. Ramtohul
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
Mannose derivatives for treating bacterial infections
- Patent number 10,407,414
- Issue date Sep 10, 2019
- Vertex Pharmaceuticals Incorporated
- Michel Gallant
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mannose derivatives for treating bacterial infections
- Patent number 9,963,478
- Issue date May 8, 2018
- Vertex Pharmaceuticals Incorporated
- Yeeman K. Ramtohul
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Mannose derivatives for treating bacterial infections
- Patent number 9,890,176
- Issue date Feb 13, 2018
- Vertex Pharmaceuticals Incorporated
- Evelyne Dietrich
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Mannose derivatives for treating bacterial infections
- Patent number 9,598,454
- Issue date Mar 21, 2017
- Vertex Pharmaceuticals Incorporated
- Yeeman K. Ramtohul
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Indole derivatives as CRTH2 receptor antagonists
- Patent number 8,637,671
- Issue date Jan 28, 2014
- Merck Canada Inc.
- John Colucci
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Case of renin inhibitors
- Patent number 8,343,968
- Issue date Jan 1, 2013
- Merck Canada Inc.
- Tom Yao-Hsiang Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Renin inhibitors
- Patent number 8,334,308
- Issue date Dec 18, 2012
- Merck Sharp & Dohme Corp.
- Helene Juteau
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Renin inhibitors
- Patent number 8,076,359
- Issue date Dec 13, 2011
- Merck Canada Inc.
- Daniel Dube
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Renin inhibitors
- Patent number 8,063,105
- Issue date Nov 22, 2011
- Merck Canada Inc.
- Christopher I. Bayly
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclo...
- Patent number 7,622,501
- Issue date Nov 24, 2009
- Merck Frosst Canada & Co.
- Claude Dufresne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
8-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitors
- Patent number 7,482,456
- Issue date Jan 27, 2009
- Merck Frosst Canada
- Daniel Dube
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-Oxo-1-3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carbox...
- Patent number 7,342,024
- Issue date Mar 11, 2008
- Merck Frost Canada Ltd.
- Daniel Dube
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
4-oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carbo...
- Patent number 7,238,706
- Issue date Jul 3, 2007
- Merck Frosst Canada, Ltd.
- Daniel Dube
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
8-(biaryl)quinoline PDE4 inhibitors
- Patent number 7,153,968
- Issue date Dec 26, 2006
- Merck Frosst Canada, Ltd.
- Daniel Dube
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
- Patent number 7,144,896
- Issue date Dec 5, 2006
- Merck Frosst Canada Ltd.
- Michel Gallant
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 8-arylquinolune PDE4 inhibitors
- Patent number 6,919,353
- Issue date Jul 19, 2005
- Merck Frosst Canada & Co.
- Daniel Dube
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
- Patent number 6,410,563
- Issue date Jun 25, 2002
- Merck Frosst Canada & Co.
- Denis Deschenes
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Carboxylic acids and acylsulfonamides, compositions containing such...
- Patent number 6,242,493
- Issue date Jun 5, 2001
- Merck Frosst Canada & Co.
- Yves Gareau
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Prostaglandin receptor ligands
- Patent number 6,211,197
- Issue date Apr 3, 2001
- Merck Frosst Canada & Co.
- Michel Belley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method for identifying inhibitors for apopain based upon the crysta...
- Patent number 5,834,228
- Issue date Nov 10, 1998
- Merck & Co., Inc.
- Joseph W. Becker
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Peptidyl derivatives as inhibitors of pro-apoptotic cysteine protei...
- Patent number 5,798,442
- Issue date Aug 25, 1998
- Merck Frosst Canada, Inc.
- Michel Gallant
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Indole derivatives with affinity for the cannabinoid receptor
- Patent number 5,532,237
- Issue date Jul 2, 1996
- Merck Frosst Canada, Inc.
- Michel Gallant
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
- Publication number 20250122218
- Publication date Apr 17, 2025
- VERTEX PHARMACEUTICALS INCORPORATED
- Jeremy J. CLEMENS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-(5-SUBSTITUTED-[(1,3,4-THIADIAZOLYL) OR (THIAZOLYL)])(SUBSTITUTED...
- Publication number 20250026748
- Publication date Jan 23, 2025
- Repare Therapeutics Inc.
- Bingcan LIU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
- Publication number 20230099745
- Publication date Mar 30, 2023
- VERTEX PHARMACEUTICALS INCORPORATED
- Jeremy J. Clemens
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Mannose Derivatives for Treating Bacterial Infections
- Publication number 20220135609
- Publication date May 5, 2022
- VERTEX PHARMACEUTICALS INCORPORATED
- Yeeman K. Ramtohul
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
- Publication number 20220041621
- Publication date Feb 10, 2022
- Vertex Pharmaceuticals Incorporated
- Jeremy J. Clemens
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Mannose Derivatives for Treating Bacterial Infections
- Publication number 20200270293
- Publication date Aug 27, 2020
- VERTEX PHARMACEUTICALS INCORPORATED
- Yeeman K. Ramtohul
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Mannose Derivatives for Treating Bacterial Infections
- Publication number 20190106450
- Publication date Apr 11, 2019
- VERTEX PHARMACEUTICALS INCORPORATED
- Yeeman K. Ramtohul
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Mannose Derivatives for Treating Bacterial Infections
- Publication number 20180244658
- Publication date Aug 30, 2018
- VERTEX PHARMACEUTICALS INCORPORATED
- Michel Gallant
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Mannose Derivatives for Treating Bacterial Infections
- Publication number 20160235775
- Publication date Aug 18, 2016
- Vertex Pharmaceuticals Incorporated.
- Yeeman K. Ramtohul
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS
- Publication number 20140274930
- Publication date Sep 18, 2014
- VERTEX PHARMACEUTICALS INCORPORATED
- Evelyne Dietrich
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS
- Publication number 20140243283
- Publication date Aug 28, 2014
- Vertex Pharmaceuticals Incorporated.
- Yeeman K. Ramtohul
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS
- Publication number 20130261077
- Publication date Oct 3, 2013
- Vertex Pharmaceuticals Incorporated.
- Youssef Laafiret Bennani
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BRIDGED LIPOGLYCOPEPTIDES THAT POTENTIATE THE ACTIVITY OF BETA-LACT...
- Publication number 20130244929
- Publication date Sep 19, 2013
- Michel Gallant
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RENIN INHIBITORS
- Publication number 20120046293
- Publication date Feb 23, 2012
- MERCK FROSST CANADA LTD
- CHRISTOPHER I. BAYLY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RENIN INHIBITORS
- Publication number 20120035214
- Publication date Feb 9, 2012
- Merck Canada Inc.
- Daniel J. McKay
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RENIN INHIBITORS
- Publication number 20110263658
- Publication date Oct 27, 2011
- Helene Juteau
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INDOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS
- Publication number 20110172263
- Publication date Jul 14, 2011
- MERCK FROSST CANADA LTD.
- John Colucci
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL CASE OF RENIN INHIBITORS
- Publication number 20100120859
- Publication date May 13, 2010
- MERCK FROSST CANADA LTD.
- Tom Yao-Hsiang Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RENIN INHIBITORS
- Publication number 20100063091
- Publication date Mar 11, 2010
- Daniel Dube
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Renin Inhibitors
- Publication number 20090281103
- Publication date Nov 12, 2009
- Christopher I. Bayly
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Combination Therapy for Treating Cyclooxygenase-2 Mediated Diseases...
- Publication number 20080242722
- Publication date Oct 2, 2008
- Claude Dufresne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Nitric Oxide Releasing Prodrugs of Diaryl-2-(5H)-Furanones as Cyclo...
- Publication number 20080242643
- Publication date Oct 2, 2008
- Claude Dufresne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
4-Oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carbo...
- Publication number 20080070940
- Publication date Mar 20, 2008
- Daniel Dube
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-oxo-1-(3-substituted phenyl)-1,4-dihydro-1,8-naphthyridine-3-carb...
- Publication number 20070099951
- Publication date May 3, 2007
- Daniel Dube
- C07 - ORGANIC CHEMISTRY
Information Patent Application
8-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitors
- Publication number 20060223850
- Publication date Oct 5, 2006
- Daniel Dube
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-Oxo-1-3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carbox...
- Publication number 20060058316
- Publication date Mar 16, 2006
- Daniel Dube
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Use of phosphodiesterase-4 inhibitors as enhancers of cognition
- Publication number 20060040981
- Publication date Feb 23, 2006
- Daniel Dube
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Hetero-bridge substituted 8-arylquinoline pde4 inhibitors
- Publication number 20050245513
- Publication date Nov 3, 2005
- Michel Gallant
- C07 - ORGANIC CHEMISTRY
Information Patent Application
8-(Biaryl)quinoline pde4 inhibitors
- Publication number 20050234238
- Publication date Oct 20, 2005
- Daniel Dube
- C07 - ORGANIC CHEMISTRY
Information Patent Application
4-Oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carbo...
- Publication number 20050107402
- Publication date May 19, 2005
- Daniel Dube
- C07 - ORGANIC CHEMISTRY

Michel Gallant

Person

Patents Grantslast 30 patents

Modulators of cystic fibrosis transmembrane conductance regulator

Mannose derivatives for treating bacterial infections

2,7-dibromospiro[fluorene-9,4′-piperidine] compounds

Mannose derivatives for treating bacterial infections

Mannose derivatives for treating bacterial infections

Mannose derivatives for treating bacterial infections

Mannose derivatives for treating bacterial infections

Mannose derivatives for treating bacterial infections

Indole derivatives as CRTH2 receptor antagonists

Case of renin inhibitors

Renin inhibitors

Renin inhibitors

Renin inhibitors

Nitric oxide releasing prodrugs of diaryl-2-(5H)-furanones as cyclo...

8-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitors

4-Oxo-1-3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carbox...

4-oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carbo...

8-(biaryl)quinoline PDE4 inhibitors

Hetero-bridge substituted 8-arylquinoline pde4 inhibitors

Substituted 8-arylquinolune PDE4 inhibitors

Substituted 8-arylquinoline phosphodiesterase-4 inhibitors

Carboxylic acids and acylsulfonamides, compositions containing such...

Prostaglandin receptor ligands

Method for identifying inhibitors for apopain based upon the crysta...

Peptidyl derivatives as inhibitors of pro-apoptotic cysteine protei...

Indole derivatives with affinity for the cannabinoid receptor

Patents Applicationslast 30 patents

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

N-(5-SUBSTITUTED-[(1,3,4-THIADIAZOLYL) OR (THIAZOLYL)])(SUBSTITUTED...

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

Mannose Derivatives for Treating Bacterial Infections

MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR

Mannose Derivatives for Treating Bacterial Infections

Mannose Derivatives for Treating Bacterial Infections

Mannose Derivatives for Treating Bacterial Infections

Mannose Derivatives for Treating Bacterial Infections

MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS

MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS

MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS

BRIDGED LIPOGLYCOPEPTIDES THAT POTENTIATE THE ACTIVITY OF BETA-LACT...

RENIN INHIBITORS

RENIN INHIBITORS

RENIN INHIBITORS

INDOLE DERIVATIVES AS CRTH2 RECEPTOR ANTAGONISTS

NOVEL CASE OF RENIN INHIBITORS

RENIN INHIBITORS

Renin Inhibitors

Combination Therapy for Treating Cyclooxygenase-2 Mediated Diseases...

Nitric Oxide Releasing Prodrugs of Diaryl-2-(5H)-Furanones as Cyclo...

4-Oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carbo...

4-oxo-1-(3-substituted phenyl)-1,4-dihydro-1,8-naphthyridine-3-carb...

8-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitors

4-Oxo-1-3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carbox...

Use of phosphodiesterase-4 inhibitors as enhancers of cognition

Hetero-bridge substituted 8-arylquinoline pde4 inhibitors

8-(Biaryl)quinoline pde4 inhibitors

4-Oxo-1-(3-substituted phenyl-1,4-dihydro-1,8-naphthyridine-3-carbo...